Improving survival in pancreatic cancer (IMAGE)
Caption
Kondo and his team found TUG1 overexpression in some pancreatic cancer patients leads to increased release of an enzyme (DPD), which breaks down the chemotherapeutic, 5-FU, into a compound that can't kill cancer cells. Targeting this pathway reduced chemotherapy resistance in mice.
Credit
Yutaka Kondo
Usage Restrictions
None
License
Licensed content